COSTA MESA, Calif.--(BUSINESS WIRE)--Feb. 28, 2006--Valeant Pharmaceuticals International (NYSE:VRX): Product Sales Advance 17 Percent in the Fourth Quarter, 21 Percent in the Year 2005 Operating Metrics Achieved. Valeant Pharmaceuticals International (NYSE:VRX) today announced fourth quarter and full year results for 2005 showing strong revenue growth and continued improvement in key operating metrics.
